Unlike in breast cancer and other tumor types such as colon cancer, there is no well-defined screening program for prostate cancer apart from the somewhat controversial use of prostate specific antigen (PSA) as a potential screening tool [14,15,16]. Here, KLK3 is linked to breast cancer.